About: http://webisa.webdatacommons.org/292337187

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	Under this pathway, the FDA may approve a product based on surrogate endpoints, or clinical endpoints other than survival or irreversible morbidity.
http://www.w3.org/ns/prov#wasQuotedFrom	sec.gov